Pharma Invest SA
Pharma Invest reported total assets of 822,626 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026).
The score of Pharma Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +14 % Total assets +17 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Invest's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 22,151 € | ||||
| Equity | 726,362 € | ||||
| Cash | 180,559 € | ||||
| EBITDA | 41,440 € | ||||
| Total assets | 822,626 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Pharma Invest's financial analysis
Management and control of Pharma Invest
Pharma Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.788.505
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 31 Mar 1993
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 24 Aug 2026
Pharma Invest (SA) has been based in Uccle since 1993, active in: —. For 2025, it reports a net profit of 22,151 € and equity of 726,362 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Invest
Companies in the same business, of comparable size and area, outside its group.
- Infirmier Guillaume Ronny Nursing and midwifery activities Châtelet · balance sheet 822,615 €
- Actimmo Rental and operating of own or leased real estate Chaumont-Gistoux · balance sheet 822,579 €
- Sumeyrsoins Nursing and midwifery activities Estinnes · balance sheet 822,723 €
- In den Brand Hechtel-Eksel · balance sheet 822,425 €
- Cajunifra Gerpinnes · balance sheet 822,843 €
- Arysteia Rental and operating of own or leased real estate Geer · balance sheet 822,872 €
- Dr. Osama Alkiar General medical practice activities Schoten · balance sheet 822,355 €
- KAVO Rental and operating of own or leased real estate Wommelgem · balance sheet 822,928 €
Frequently asked questions about Pharma Invest
What is the revenue of Pharma Invest?
Pharma Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Invest?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Pharma Invest. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0449788505. Its company number (CBE) is 0449.788.505.
Where is the registered office of Pharma Invest?
According to the CBE register, the registered office of Pharma Invest is in 1180 Uccle.
What is the equity of Pharma Invest?
At the close of the 2025 financial year, the equity of Pharma Invest amounts to 726,362 €, a solvency of 88.3% of total assets.
Who manages Pharma Invest?
The register lists 4 active mandates at Pharma Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →